Adjust Font Size:

Press Releases

Advanced Cell Technology Names Jonathan F. Atzen as General Counsel

Worcester, MA, April 20, 2005 - William Caldwell, IV, Chief Executive Officer of A.C.T. Holdings, Inc. (OTC Bulletin Board: ACTH.OB) and its wholly-owned subsidiary, Advanced Cell Technology, Inc., a leading biotechnology company applying stem cell technology in the emerging field of regenerative medicine, announced today the appointment of Jonathan F. Atzen as Senior Vice President and General Counsel, effective April 1, 2005. This announcement completes the hiring of the senior management team.

Since 2003, Mr. Atzen was an attorney at Heller Ehrman/Venture Law Group LLP, an international full-service law firm. Prior to 2003, Mr. Atzen worked as a corporate/securities attorney for other large international law firms including Brobeck, Phleger & Harrison LLP and Morrison & Foerster LLP. His corporate practice has focused on the representation of emerging growth and established technology companies in such industries as life sciences, semiconductors, wireless communications, software and alternative energy technologies. He has significant experience with venture capital financings representing companies and venture capital funds. Mr. Atzen has provided general corporate counsel to public companies with respect to securities offerings including initial public offerings, secondary offerings, PIPEs and spin-offs, and reporting and compliance matters under the Securities Exchange Act of 1934. Mr. Atzen also has experience in public and private company mergers and acquisitions.

"I am very excited to announce that Jon Atzen has joined us as General Counsel of Advanced Cell Technology. His extensive background in life sciences and corporate law make him a significant addition to the team,�? said William Caldwell. "This addition rounds out the recent hiring of our executive management team of industry professionals.�?

"Advanced Cell Technology has offered me the unique opportunity to work as General Counsel for a company that is leading the way in the field of regenerative medicine,�? said Jon Atzen. "I am both honored and excited to be joining this management team and the renowned scientific team led by Dr. Michael West and Dr. Robert Lanza.�?

Mr. Atzen received his B.A. degree in Economics from the University of California at Santa Barbara, and holds a J.D from Loyola Law School.

For a complete list of Advanced Cell Technology's senior management visit "":

About Advanced Cell Technology

A.C.T. Holdings, Inc., a Nevada corporation, and its wholly-owned subsidiary, Advanced Cell Technology, Inc., a Delaware corporation, is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company is currently headquartered in Worcester, Massachusetts.

For more information about Advanced Cell Technology visit "":

Forward-Looking Statements

This press release contains forward looking statements that involve risks and uncertainties. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties that may cause the company's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. You should not place undue reliance on forward-looking statements because they involve these risks and uncertainties. You should independently investigate and fully understand all risks before making investment decisions.
A.C.T. Holdings, Inc.

Press Contact

Chad Griffin
Noelle Gambill
(310) 888-3523

Download PDF


To view PDF Files, you must have Acrobat Reader.

Download Adobe Acrobat